Evidence map›Paper›PMID 33149807›Full record

ArticleOxidative medicine and cellular longevity2020

Antitumor Therapy under Hypoxic Microenvironment by the Combination of 2-Methoxyestradiol and Sodium Dichloroacetate on Human Non-Small-Cell Lung Cancer.

Yair Romero, Manuel Castillejos-López, Susana Romero-García, Alfonso Salgado Aguayo, Iliana Herrera, Misael O Garcia-Martin, Luz Maria Torres-Espíndola, Maria Cristina Negrete-García, Angel Camarena Olvera, Juan Carlos Huerta-Cruz and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Dichloroacetate and Salinomycin as Therapeutic Agents in Cancer.Medical sciences (Basel, Switzerland) · 2025
    Review
  3. Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Yair RomeroFacultad de Ciencias, Universidad Nacional Autónoma de México, CDMX, Mexico.ORCID https://orcid.org/0000-0002-8707-025X
Manuel Castillejos-LópezInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Susana Romero-GarcíaInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Alfonso Salgado AguayoInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Iliana HerreraInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Misael O Garcia-MartinInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Luz Maria Torres-EspíndolaInstituto Nacional de Pediatría, CDMX, Mexico.
Maria Cristina Negrete-GarcíaInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Angel Camarena OlveraInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Juan Carlos Huerta-CruzInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Rafael Velazquez CruzInstituto Nacional de Medicina Genómica, CDMX, Mexico.
José CisnerosInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Edgar Flores SotoFacultad de Medicina, Universidad Nacional Autónoma México, CDMX, Mexico.
Héctor Solís-ChagoyánInstituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", CDMX, Mexico.ORCID https://orcid.org/0000-0003-0692-6931
Criselda Mendoza-MillaInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Carlos Cabello-GutiérrezInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.
Víctor RuizInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.ORCID https://orcid.org/0000-0003-0440-2093
Arnoldo Aquino-GálvezInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", CDMX, Mexico.ORCID https://orcid.org/0000-0002-2869-5516
Instituto Nacional de Enfermedades Respiratorias · MXUniversidad Nacional Autónoma de México · MXInstituto Nacional de Pediatria · MXInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz · MXNational Institute of Genomic Medicine · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hypoxic microenvironment is a hallmark in different types of tumors; this phenomenon participates in a metabolic alteration that confers resistance to treatments. Because of this, it was proposed that a combination of 2-methoxyestradiol (2-ME) and sodium dichloroacetate (DCA) could reduce this alteration, preventing proliferation through the reactivation of aerobic metabolism in lung adenocarcinoma cell line (A549). A549 cells were cultured in a hypoxic chamber at 1% O

Indexed as

Tumor HypoxiaTumor Microenvironment2-MethoxyestradiolA549 CellsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsApoptosis Regulatory ProteinsBasic Helix-Loop-Helix ProteinsCarcinoma, Non-Small-Cell LungCell MovementCell ProliferationDichloroacetic AcidEndothelial PAS Domain-Containing Protein 1GlucoseGlutamic AcidGlutamine2-MethoxyestradiolAntineoplastic AgentsApoptosis Regulatory ProteinsBasic Helix-Loop-Helix ProteinsDichloroacetic AcidEndothelial PAS Domain-Containing Protein 1GlucoseGlutamic AcidGlutamineHIF3A protein, humanHypoxia-Inducible Factor 1, alpha SubunitLactic AcidRepressor Proteins

Identifiers

PMID33149807
PMCPMC7603622
OpenAlexW3094620992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.